sample_id	patient_name	dataset_id	dataset_group	Treatment	response	response_NR	M Stage	overall survival (days)	vital status	Total Mutation	Gender	Therapy	age_start	tumor_type	seq_type	id
SRR8281218	Pt20	PRJNA482620	GBM_PRJNA482620	PRE	N	N		1033	Dead	94.0	Male	anti-PD-1	63	GBM	RNA-seq	GBM_PRJNA482620_anti-PD-1
SRR8281219	Pt20	PRJNA482620	GBM_PRJNA482620	PRE	N	N		1033	Dead	94.0	Male	anti-PD-1	63	GBM	RNA-seq	GBM_PRJNA482620_anti-PD-1
SRR8281220	Pt21	PRJNA482620	GBM_PRJNA482620	PRE	N	N		312	Dead	32.0	Male	anti-PD-1	59	GBM	RNA-seq	GBM_PRJNA482620_anti-PD-1
SRR8281221	Pt20	PRJNA482620	GBM_PRJNA482620	PRE	N	N		1033	Dead	94.0	Male	anti-PD-1	63	GBM	RNA-seq	GBM_PRJNA482620_anti-PD-1
SRR8281222	Pt13	PRJNA482620	GBM_PRJNA482620	PRE	N	N		1692	Dead	69.0	Female	anti-PD-1	55	GBM	RNA-seq	GBM_PRJNA482620_anti-PD-1
SRR8281223	Pt21	PRJNA482620	GBM_PRJNA482620	PRE	N	N		312	Dead	32.0	Male	anti-PD-1	59	GBM	RNA-seq	GBM_PRJNA482620_anti-PD-1
SRR8281224	Pt13	PRJNA482620	GBM_PRJNA482620	PRE	N	N		1692	Dead	69.0	Female	anti-PD-1	55	GBM	RNA-seq	GBM_PRJNA482620_anti-PD-1
SRR8281225	Pt13	PRJNA482620	GBM_PRJNA482620	PRE	N	N		1692	Dead	69.0	Female	anti-PD-1	55	GBM	RNA-seq	GBM_PRJNA482620_anti-PD-1
SRR8281226	Pt53	PRJNA482620	GBM_PRJNA482620	PRE	N	N		951	Dead	75.0	Male	anti-PD-1	70	GBM	RNA-seq	GBM_PRJNA482620_anti-PD-1
SRR8281227	Pt53	PRJNA482620	GBM_PRJNA482620	PRE	N	N		951	Dead	75.0	Male	anti-PD-1	70	GBM	RNA-seq	GBM_PRJNA482620_anti-PD-1
SRR8281228	Pt3	PRJNA482620	GBM_PRJNA482620	PRE	R	R		774	Alive	38.0	Male	anti-PD-1	41	GBM	RNA-seq	GBM_PRJNA482620_anti-PD-1
SRR8281229	Pt24	PRJNA482620	GBM_PRJNA482620	PRE	R	R		1112	Alive	26.0	Female	anti-PD-1	33	GBM	RNA-seq	GBM_PRJNA482620_anti-PD-1
SRR8281230	Pt56	PRJNA482620	GBM_PRJNA482620	PRE	N	N		595	Dead	81.0	Female	anti-PD-1	54	GBM	RNA-seq	GBM_PRJNA482620_anti-PD-1
SRR8281231	Pt3	PRJNA482620	GBM_PRJNA482620	PRE	R	R		774	Alive	38.0	Male	anti-PD-1	41	GBM	RNA-seq	GBM_PRJNA482620_anti-PD-1
SRR8281232	Pt69	PRJNA482620	GBM_PRJNA482620	PRE	N	N		465	Dead	55.0	Female	anti-PD-1	66	GBM	RNA-seq	GBM_PRJNA482620_anti-PD-1
SRR8281233	Pt56	PRJNA482620	GBM_PRJNA482620	PRE	N	N		595	Dead	81.0	Female	anti-PD-1	54	GBM	RNA-seq	GBM_PRJNA482620_anti-PD-1
SRR8281234	Pt46	PRJNA482620	GBM_PRJNA482620	PRE	N	N		1380	Alive	47.0	Female	anti-PD-1	63	GBM	RNA-seq	GBM_PRJNA482620_anti-PD-1
SRR8281235	Pt69	PRJNA482620	GBM_PRJNA482620	PRE	N	N		465	Dead	55.0	Female	anti-PD-1	66	GBM	RNA-seq	GBM_PRJNA482620_anti-PD-1
SRR8281236	Pt53	PRJNA482620	GBM_PRJNA482620	PRE	N	N		951	Dead	75.0	Male	anti-PD-1	70	GBM	RNA-seq	GBM_PRJNA482620_anti-PD-1
SRR8281237	Pt46	PRJNA482620	GBM_PRJNA482620	PRE	N	N		1380	Alive	47.0	Female	anti-PD-1	63	GBM	RNA-seq	GBM_PRJNA482620_anti-PD-1
SRR8281238	Pt102	PRJNA482620	GBM_PRJNA482620	PRE	R	R		729	Alive	39.0	Female	anti-PD-1	64	GBM	RNA-seq	GBM_PRJNA482620_anti-PD-1
SRR8281239	Pt103	PRJNA482620	GBM_PRJNA482620	PRE	R	R		438	Alive		Male	anti-PD-1	63	GBM	RNA-seq	GBM_PRJNA482620_anti-PD-1
SRR8281240	Pt104	PRJNA482620	GBM_PRJNA482620	PRE	R	R		1414	Alive		Female	anti-PD-1	41	GBM	RNA-seq	GBM_PRJNA482620_anti-PD-1
SRR8281241	Pt104	PRJNA482620	GBM_PRJNA482620	PRE	R	R		1414	Alive		Female	anti-PD-1	41	GBM	RNA-seq	GBM_PRJNA482620_anti-PD-1
SRR8281242	Pt101	PRJNA482620	GBM_PRJNA482620	PRE	R	R		1386	Dead	66.0	Male	anti-PD-1	32	GBM	RNA-seq	GBM_PRJNA482620_anti-PD-1
SRR8281243	Pt101	PRJNA482620	GBM_PRJNA482620	PRE	R	R		1386	Dead	66.0	Male	anti-PD-1	32	GBM	RNA-seq	GBM_PRJNA482620_anti-PD-1
SRR8281244	Pt100	PRJNA482620	GBM_PRJNA482620	PRE	R	R		1425	Alive	23.0	Male	anti-PD-1	31	GBM	RNA-seq	GBM_PRJNA482620_anti-PD-1
SRR8281245	Pt100	PRJNA482620	GBM_PRJNA482620	PRE	R	R		1425	Alive	23.0	Male	anti-PD-1	31	GBM	RNA-seq	GBM_PRJNA482620_anti-PD-1
SRR8281246	Pt71	PRJNA482620	GBM_PRJNA482620	PRE	R	R		485	Dead	47.0	Male	anti-PD-1	69	GBM	RNA-seq	GBM_PRJNA482620_anti-PD-1
SRR8281247	Pt55	PRJNA482620	GBM_PRJNA482620	PRE	R	R		704	Alive	84.0	Male	anti-PD-1	66	GBM	RNA-seq	GBM_PRJNA482620_anti-PD-1
SRR8281248	Pt55	PRJNA482620	GBM_PRJNA482620	PRE	R	R		704	Alive	84.0	Male	anti-PD-1	66	GBM	RNA-seq	GBM_PRJNA482620_anti-PD-1
SRR8281249	Pt25	PRJNA482620	GBM_PRJNA482620	PRE	R	R		1626	Dead	25.0	Female	anti-PD-1	34	GBM	RNA-seq	GBM_PRJNA482620_anti-PD-1
SRR8281250	Pt102	PRJNA482620	GBM_PRJNA482620	PRE	R	R		729	Alive	39.0	Female	anti-PD-1	64	GBM	RNA-seq	GBM_PRJNA482620_anti-PD-1
SRR8281251	Pt101	PRJNA482620	GBM_PRJNA482620	PRE	R	R		1386	Dead	66.0	Male	anti-PD-1	32	GBM	RNA-seq	GBM_PRJNA482620_anti-PD-1
